1-(4-methoxyphenyl)pyridinium has been researched along with Atherosclerotic Parkinsonism in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Drobitch, R; Hagg, T; Robertson, H; Van Kampen, J | 1 |
Guerra, MJ; Labandeira-Garcia, JL; Mendez-Alvarez, E; Muñoz, A; Rey, P; Soto-Otero, R | 1 |
Forno, LS; Irwin, I; Langston, EB; Langston, JW | 1 |
López Alemany, M | 1 |
4 other study(ies) available for 1-(4-methoxyphenyl)pyridinium and Atherosclerotic Parkinsonism
Article | Year |
---|---|
Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Dopamine Agents; Dose-Response Relationship, Drug; Female; Immunohistochemistry; Locomotion; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Panax; Parkinson Disease, Secondary; Phytotherapy; Plant Extracts; Pyridinium Compounds; Rats; Rats, Sprague-Dawley | 2003 |
Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Angiotensin-Converting Enzyme Inhibitors; Animals; Antiparkinson Agents; Captopril; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Immunohistochemistry; In Vitro Techniques; Lipid Peroxidation; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Mitochondria; Monoamine Oxidase; Neostriatum; Nerve Degeneration; Nerve Endings; Nerve Tissue Proteins; Neuroprotective Agents; Oxidative Stress; Parkinson Disease, Secondary; Pyridinium Compounds; Synaptosomes; Tyrosine 3-Monooxygenase | 2006 |
Pargyline prevents MPTP-induced parkinsonism in primates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain Chemistry; Male; Neurons; Pargyline; Parkinson Disease, Secondary; Pyridines; Pyridinium Compounds; Saimiri; Substantia Nigra | 1984 |
Parkinsonism as late toxic effect of dihydropyridines?
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Humans; Parkinson Disease, Secondary; Pyridines; Pyridinium Compounds; Time Factors | 1986 |